IHS, LLC. Acquires Prestigious BC Healthcare Practice to Enhance Patient Care and Expand Services
IHS, LLC., a leading business acquisitions and management firm, along with its physician partners, proudly announces the ...
University of California, San Francisco1d
International Stroke Conference Features UCSF Experts
Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...
Endovascular Today6d
Arsenal’s EMBO-02 Study of NeoCast for cSDH Treatment Enrolls Initial Cohort
Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s ...
The Heartland Institute10d
Controversial Brain Death Diagnoses Under Fire
Numerous patients’ rights advocacy groups suggest the Uniform Determination of Death Act (UDDA) is a flawed standard that ...
Endovascular Today2d
Guerbet’s Lipiojoint Liquid Embolic Granted FDA Breakthrough Device Status
Guerbet announced that its Lipiojoint transient liquid embolic agent received Breakthrough Device status from the United State ...
jnis.bmj1d
Antithrombotic resumption after middle meningeal artery embolization or surgery for chronic subdural hematoma: a systematic review and meta-analysis
Background The periprocedural management of antithrombotic medications in patients with chronic subdural hematoma (cSDH) after middle meningeal artery embolization (MMAE) or surgical evacuation is ...
ahajournals.org14d
Abstract WP251: Middle meningeal artery embolization using Onyx and particles for chronic subdural hematoma: A single center experience.
Middle meningeal artery (MMA) embolization is being utilized more frequently as adjunctive and primary treatment. It has demonstrated beneficial effects on recurrence and progression of cSDH. Here, we ...